August 30 01:24 PM
Low-cost drugs, ill-gotten gains
Some major American healthcare providers are padding their bottom lines by exploiting a federal program meant to help lowincome patients. This behavior is netting them billions in ill-gotten gains. And it could be preventing many vulnerable Americans from accessing the low-cost drugs they need to treat and prevent illness.
To continue reading, please login as a subscriber.